title: [Intracranial hypertension and lupus].
abstract: BACKGROUND
  Idiopathic intracranial hypertension (IH) occurs most commonly in women and overweight subjects. It must be reported associated to general diseases, like systemic lupus erythematosus (SLE).
  
  
  METHODS
  We report an observation of a patient with lupus complicated by glomerulonephritis and IH.
  
  
  METHODS
  A 29 years old woman, without overweight, was followed for a SLE with skin and arthritic involvement . Four years after onset, a renal complication appeared with severe nephrotic syndrome. Six weeks after, bilateral papillar oedema was discovered, revealing an IH, as the patient was treated by oral steroids at 1mg/kg/d and bimonthly intravenous cyclophosphamide. The patient was completely asymptomatic. Brain MRI with veino-RMN was normal, without cerebral venous thrombosis. Lumbar punction showed an elevated opening pressure of 30,5 cmH(2)0 but with normal cerebrospinal fluid (CSF) contents. Evacuation of 30 mL of CSF and immunosuppressive treatment allowed symptoms regression.
  
  
  CONCLUSIONS
  Twenty-seven cases of IH associated to SLE with nephritis have been reported in literature. Young women are more frequently involved with in half of cases a diffuse proliferative glomerulonephritis. Predisposing factors, like anaemia, must be associated. IH allows SLE diagnose in more than the third of the cases. Then, SLE has to be searched as an etiology of IH, in particular in non-obese patients and when nephritis is associated.
authors.affiliation: Service de Neurologie, Fondation Ophtalmologique A-de-Rothschild, 25-29 rue Manin, 75940 Paris cedex 9, France. emaillart@fo-rothschild.fr
authors.forename: E
authors.initials: E
authors.lastname: Maillart
authors.forename: A
authors.initials: A
authors.lastname: Gueguen
authors.forename: M
authors.initials: M
authors.lastname: Obadia
authors.forename: A
authors.initials: A
authors.lastname: Moulignier
authors.forename: C
authors.initials: C
authors.lastname: Vignal-Clermont
authors.forename: O
authors.initials: O
authors.lastname: Gout
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000792:Angiography; D003520:Cyclophosphamide / Q000627:therapeutic use; D005123:Eye / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019586:Intracranial Hypertension / Q000209:etiology / Q000503:physiopathology*; D007681:Kidney Papillary Necrosis / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000503:physiopathology*; D008279:Magnetic Resonance Imaging; D009404:Nephrotic Syndrome / Q000209:etiology; D009460:Neurologic Examination; D009898:Optic Disk / Q000473:pathology; D009900:Optic Nerve / Q000473:pathology
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide